ScholarLens Back to search
2016•BloodRequires access

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia

Hongming Zhu, Jiong Hu, Li Chen, Wei Zhou, Xiaoyang Li, Lining Wang, Xia Zhao, Yunxiang Zhang, Huijin Zhao, Aihua Wang, Yú Chen, Huiping Sun, Qiusheng Chen, Yù Chen, Weili Zhao, Jian‐Qing Mi, Zhixiang Shen, Zhenyi Wang, Zhu Chen, Sai‐Juan Chen, Junmin Li

Open publisher page 72 citations

Abstract

To the editor: Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) have demonstrated notable success in the treatment of acute promyelocytic leukemia (APL).[1][1][⇓][2]-[3][3] However, few studies have reported the adverse effects (AEs), long-term toxicity, and secondary carcinogenesis of

About this research paper

What this paper is about

To the editor: Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) have demonstrated notable success in the treatment of acute promyelocytic leukemia (APL).[1][1][⇓][2]-[3][3] However, few studies have reported the adverse effects (AEs), long-term toxicity, and secondary carcinogenesis of

Why it matters

OpenAlex reports 72 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the editor: Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) have demonstrated notable success in the treatment of acute promyelocytic leukemia (APL).[1][1][⇓][2]-[3][3] However, few studies have reported the adverse effects (AEs), long-term toxicity, and secondary carcinogenesis of

Key concepts: Arsenic trioxide, Acute promyelocytic leukemia, Adverse effect, Medicine, Tretinoin, Retinoic acid, Arsenic, Leukemia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia — Research Paper | ScholarLens